Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Opal

Showing results (51-60 of 168) with videos related to

Pageof 17
Sort By:
The Lancet. Infectious Diseases|May 1, 2012
Research into transmissibility of influenza A H5N1: a practical response to the controversyDavid S Fedson, Steven M Opal
The Medical Clinics of North America|August 22, 2018
Antibiotic Stewardship: Strategies to Minimize Antibiotic Resistance While Maximizing Antibiotic EffectivenessCheston B Cunha, Steven M Opal
Critical Care Medicine|October 29, 2013
The authors replySteven M Opal, R Philip Dellinger
American Journal of Respiratory and Critical Care Medicine|September 15, 2017
The Role of S1PR3 in Protection from Bacterial SepsisBarry S Shea, Steven M Opal
Critical Care (London, England)|July 10, 2013
Over-distension of the airways by mechanical ventilation in the elderly: adding insult to injuryAurora Pop-Vicas, Steven M Opal
Human Vaccines & Immunotherapeutics|February 9, 2013
The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threatDavid S Fedson, Steven M Opal
Journal of Innate Immunity|April 19, 2013
Prognostic value of endotoxemia in patients with Gram-negative bacteremia is bacterial species dependentJames C Hurley, Steven M Opal
American Journal of Respiratory and Critical Care Medicine|May 17, 2013
Recombinant human activated protein C as a therapy for severe sepsis: lessons learned?Steven M Opal, Steven P LaRosa
Annals of Internal Medicine|March 18, 2003
A new paradigm for the treatment of sepsis: is it time to consider combination therapy?Alan S Cross, Steven M Opal
Critical Care (London, England)|March 19, 2010
Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumoniaMirjam Christ-Crain, Steven M Opal
Pageof 17

Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
The Lancet. Infectious Diseases|May 1, 2012
Research into transmissibility of influenza A H5N1: a practical response to the controversyDavid S Fedson, Steven M Opal
The Medical Clinics of North America|August 22, 2018
Antibiotic Stewardship: Strategies to Minimize Antibiotic Resistance While Maximizing Antibiotic EffectivenessCheston B Cunha, Steven M Opal
Critical Care Medicine|October 29, 2013
The authors replySteven M Opal, R Philip Dellinger
American Journal of Respiratory and Critical Care Medicine|September 15, 2017
The Role of S1PR3 in Protection from Bacterial SepsisBarry S Shea, Steven M Opal
Critical Care (London, England)|July 10, 2013
Over-distension of the airways by mechanical ventilation in the elderly: adding insult to injuryAurora Pop-Vicas, Steven M Opal
Human Vaccines & Immunotherapeutics|February 9, 2013
The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threatDavid S Fedson, Steven M Opal
Journal of Innate Immunity|April 19, 2013
Prognostic value of endotoxemia in patients with Gram-negative bacteremia is bacterial species dependentJames C Hurley, Steven M Opal
American Journal of Respiratory and Critical Care Medicine|May 17, 2013
Recombinant human activated protein C as a therapy for severe sepsis: lessons learned?Steven M Opal, Steven P LaRosa
Annals of Internal Medicine|March 18, 2003
A new paradigm for the treatment of sepsis: is it time to consider combination therapy?Alan S Cross, Steven M Opal
Critical Care (London, England)|March 19, 2010
Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumoniaMirjam Christ-Crain, Steven M Opal
Pageof 17